Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

News

HomeHome / News / Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Nov 04, 2024

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Optical Genome Mapping Market Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's

Optical Genome Mapping Market

Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The global optical genome mapping market is estimated to reach USD 536.4 million by 2030. The market is projected to grow at a CAGR of 26.76% from 2024 to 2030. This can be attributed to developments in studying efficient treatments for a variety of chronic diseases. The ability of optical genome mapping (OGM) to complement other genomic sequencing technologies, such as next-generation sequencing (NGS), has created synergies in genomics research.

Based on region, North America dominated the market in 2023 with the largest revenue share of 45.07%, owing to the growing investments and funding in the biotechnology sector.

Researchers can integrate optical mapping data with NGS data to obtain a more comprehensive view of the genome, which is particularly valuable in clinical diagnostics and cancer research. In August 2023, Bionano Genomics participated in the Cancer Genomics Consortium (CGC) 2023 annual meeting with a wide range of sessions covering the utility of OGM for hematological malignancy and solid tumor cancer research, including poster presentations and scientific platform from Bionano Genomics, which also featured a panel discussion of esteemed researchers from across the cancer genomics field.Technological advancements have played a significant role in the growth of the OGM industry. Over the years, there have been substantial improvements in the underlying technologies used in optical mapping. High-resolution imaging techniques, such as fluorescence microscopy, have become more sophisticated, enabling researchers to visualize and analyze individual DNA molecules with unprecedented precision. Advancements in DNA labeling methods and data analysis algorithms have enhanced the accuracy and efficiency of OGM, making it a reliable and robust tool for genomic research. In June 2023, Bionano Genomics introduced the Stratys system for high throughput OGM via software for evaluating genomic data for hematologic malignancies.Moreover, the accessibility of optical mapping technology has also improved, making it more widely available to researchers and institutions. Several companies have developed commercial optical mapping platforms, offering turnkey solutions for genomics research. This commercialization has not only made optical mapping more accessible but has also accelerated its adoption across different sectors.Optical Genome Mapping Market Report Highlights

Based on product, the market is segmented into instruments, consumables and reagents, software, services, and others. The services segment dominated the market with a revenue share of 64.74% in 2023. This is attributed to the technological advancements in instruments and the increasing number of service providers. The consumables and reagents segment is expected to grow at a lucrative CAGR over the forecast period

Based on application, the structural variant detection segment dominated the market in 2023. In contrast, the genome assembly segment is anticipated to exhibit the second fastest CAGR over the forecast period owing to the expanding research on gene expressions, genomic diversity, and complex data sequencing

Based on end-users, the academic research institutes segment dominated the market in 2023 with a revenue share of 59.87%. On the other hand, the hospitals and clinical laboratories segment is expected to grow at a lucrative CAGR of 30.48% owing to the increasing investment in new drug targets and therapeutic approaches

Why should you buy this report?

Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.

Competitive Landscape: Explore the market presence of key players worldwide.

Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.

Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

Market intelligence to enable effective decision-making

Market estimates and forecasts from 2018 to 2030

Growth opportunities and trend analyses

Segment and regional revenue forecasts for market assessment

Competition strategy and market share analysis

Product innovation listing for you to stay ahead of the curve

COVID-19's impact and how to sustain in these fast-evolving markets

Key Attributes

Report Attribute

Details

No. of Pages

120

Forecast Period

2023-2030

Estimated Market Value (USD) in 2023

$104.1 Million

Forecasted Market Value (USD) by 2030

$536.4 Million

Compound Annual Growth Rate

26.7%

Regions Covered

Global

Key Topics CoveredChapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Snapshot2.2. Segment Snapshot2.3. Competitive Landscape SnapshotChapter 3. Market Variables, Trends, & Scope3.1. Market Lineage Outlook3.1.1. Parent Market Outlook3.1.2. Related/Ancillary Market Outlook3.2. Market Dynamics3.2.1. Market Driver Analysis3.2.1.1. Advancements in Genomic Research3.2.1.2. Rising Government Funding and Research Initiatives3.2.2. Market Restraint Analysis3.2.2.1. High Cost of Equipment and Consumables3.3. Industry Analysis Tools3.3.1. Porter's Five Forces Analysis3.3.2. PESTEL Analysis3.3.3. COVID-19 Impact AnalysisChapter 4. Product & Service Business Analysis4.1. Product & Service Segment Dashboard4.2. Global Optical Genome Mapping Market Product & Service Movement Analysis4.3. Global Optical Genome Mapping Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)4.4. Instruments4.5. Consumables & Reagents4.6. Software4.7. Services

Chapter 5. Technique Business Analysis5.1. Technique Segment Dashboard5.2. Global Optical Genome Mapping Market Technique Movement Analysis5.3. Global Optical Genome Mapping Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)5.4. Structural Variant Detection5.5. Genome Assembly5.6. Microbial Strain Typing5.7. Others

Chapter 6. Application Business Analysis6.1. Application Segment Dashboard6.2. Global Optical Genome Mapping Market Application Movement Analysis6.3. Global Optical Genome Mapping Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)6.4. Research6.5. Diagnostics

Chapter 7. End Use Business Analysis7.1. End Use Segment Dashboard7.2. Global Optical Genome Mapping Market End Use Movement Analysis7.3. Global Optical Genome Mapping Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)7.4. Biotechnology & Pharmaceutical Companies7.5. Hospitals & Clinical Laboratories7.6. Academic Research Institutes

Chapter 8. Optical Genome Mapping Market: Regional Estimates & Trend Analysis by Product & Service, Technique, Application, and End Use8.1. Regional Market Dashboard8.2. Market Size, & Forecasts Trend Analysis, 2018 to 20308.3. North America8.4. Europe8.5. Asia Pacific8.6. Latin America8.7. Middle East & AfricaChapter 9. Competitive Landscape9.1. Company Categorization9.2. Strategy Mapping9.3. Company Market Position Analysis, 20239.4. Company Profiles9.4.1. Bionano Genomics9.4.2. Nucleome Informatics Private Limited9.4.3. Praxis Genomics, LLC9.4.4. SourceBio International Limited (Source BioScience)9.4.5. MedGenome9.4.6. INRAE (French Plant Genomic Resources Center (CNRGV))9.4.7. PerkinElmer (PerkinElmer Genomics)9.4.8. Genohub Inc.9.4.9. Hofkens Lab9.4.10. Cerba

For more information about this report visit https://www.researchandmarkets.com/r/fz67t8

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

Optical Genome Mapping Market

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

ResearchAndMarkets.com'sOptical Genome Mapping Market Report HighlightsWhy should you buy this report?This report addresses:Key AttributesReport AttributeDetailsKey Topics CoveredChapter 1. Methodology and ScopeChapter 2. Executive SummaryChapter 3. Market Variables, Trends, & ScopeChapter 4. Product & Service Business AnalysisChapter 5. Technique Business AnalysisChapter 6. Application Business AnalysisChapter 7. End Use Business AnalysisChapter 8. Optical Genome Mapping Market: Regional Estimates & Trend Analysis by Product & Service, Technique, Application, and End UseChapter 9. Competitive LandscapeAbout ResearchAndMarkets.comAttachment